Vimarsana
Biggest News Aggregation in the World

Page 6 - Quantumdx Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Quantumdx Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Quantumdx Group Today - Breaking & Trending Today

Prime Minister, Boris Johnson visits Newcastle-based QuantuMDx - Vimarsana News

Prime Minister, Boris Johnson visits Newcastle-based QuantuMDx

Prime Minister, Boris Johnson visits Newcastle-based QuantuMDx February 13, 2021 10:30 ET | Source: QuantuMDx Group Ltd QuantuMDx Group Ltd Prime Minister, Boris Johnson visits Newcastle-based QuantuMDx                    -          QuantuMDx has developed Q-POC™ - a rapid, PCR diagnostic device for coronavirus testing at the point of care                NEWCASTLE UPON TYNE, UK, 13 February 2021. QuantuMDx Group Limited, a UK-based diagnostics company which has developed a revolutionary 30 minute PCR diagnostics device, Q-PO...

British scientists are developing 'universal Covid jab' to beat all variants - Vimarsana News

British scientists are developing 'universal Covid jab' to beat all variants

Nottingham University researchers are working with Oxford-based cancer vaccine firm Scancell (pictured, its chief medical officer) to create the universal vaccine.

Point-of-Care Infectious Disease Diagnostics Market Expectations to Reach at 14.5% CAGR by 2025 - Vimarsana News

Point-of-Care Infectious Disease Diagnostics Market Expectations to Reach at 14.5% CAGR by 2025

Global Point of Care Infectious Disease Diagnostics Market – InsightsPoint-of-care (POC) diagnostic testing allows patient diagnoses in the physician’s office, home, an ambulance, the field, or in the hospital. POC allows rapid and timely treatment to patient. Infectious diseases often need to be diagnosed early, as...

QuantuMDx diagnostic test for SARS-CoV-2 remains suitable for the detection of all discovered variants, including VUI-202012/01 | Comunicados | Edición USA - Vimarsana News

QuantuMDx diagnostic test for SARS-CoV-2 remains suitable for the detection of all discovered variants, including VUI-202012/01 | Comunicados | Edición USA

QuantuMDx diagnostic test for SARS-CoV-2 remains suitable for the detection of all discovered variants, including VUI-202012/01 NEWCASTLE UPON TYNE, UK, 22 December 2020. QuantuMDx Group Limited (“QuantuMDx”), a UK-based life sciences company developing transformational point-of-care molecular diagnostics, today confirms its diagnostic assay for SARS-CoV-2 remains suitable for detecting all available virus strains, following the identification of a new strain of SARS-CoV-2. The UK COVID Genomics Consortium and Public Health England have identified a new strain of SARS-CoV-2 which is char...

Source: efe.com
QuantuMDx Group Ltd: QuantuMDx diagnostic test for SARS-CoV-2 remains suitable for the detection of all discovered variants, including VUI-202012/01 - Vimarsana News

QuantuMDx Group Ltd: QuantuMDx diagnostic test for SARS-CoV-2 remains suitable for the detection of all discovered variants, including VUI-202012/01

(1) QuantuMDx diagnostic test for SARS-CoV-2 remains suitable for the detection of all discovered variants, including VUI-202012/01 NEWCASTLE UPON TYNE, UK, 22 December 2020. QuantuMDx Group Limited ("QuantuMDx"), a UK-based life sciences company developing transformational point-of-care molecular diagnostics, today confirms its diagnostic assay for SARS-CoV-2 remains suitable for detecting all available virus strains, following the identification of a new strain of SARS-CoV-2. The UK COVID Genomics Consortium and Public Health England have identified a new strain of SARS-CoV-2 which is char...